MiNK Therapeutics (INKT) Earnings Date, Estimates & Call Transcripts $10.86 +0.23 (+2.16%) As of 03:35 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings MiNK Therapeutics Earnings Summary MiNK Therapeutics released Q2 2026 earnings on August 13, 2026, reporting an EPS of -$0.62, which missed the consensus estimate of -$0.60 by $0.02. With a trailing EPS of -$2.40, MiNK Therapeutics' earnings are expected to grow next year, from ($2.20) to ($2.19) per share. Upcoming Q3 Earnings DateNov. 12Before Market OpensEstimatedConsensus EPS (Aug. 13) -$0.60 Actual EPS (Aug. 13) -$0.62 Missed By -$0.02 Q2 2026 Earnings ResourcesQ2 2026 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)SEC FilingINKT Upcoming EarningsMiNK Therapeutics' Q3 2026 earnings is estimated for Thursday, November 12, 2026, based on past reporting schedules, with a conference call scheduled on Friday, November 13, 2026 at 8:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get MiNK Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on MiNK Therapeutics and other key companies, straight to your inbox. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataINKT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. MiNK Therapeutics Upcoming Earnings ConsensusReport DateNovember 12, 2026Consensus EPS Estimate-$0.50Consensus Revenue Estimate$0.88MMiNK Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20262-$0.77-$0.71-$0.74Q2 20262-$0.73-$0.60-$0.67Q3 20262-$0.71-$0.35-$0.53Q4 20262-$0.68-$0.39-$0.54FY 20268-$2.89-$2.05-$2.47 MiNK Therapeutics Earnings History by Quarter 10/28/2024 - 10/28/2026 Report Date Report Date From Report Date To 3M6MYTD1Y2Y3Y5Y10Y More filters Fewer filters Done 0 Results Export DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/12/2026(Estimated)--$0.50---$0.88M--8/13/2026Q2 2026-$0.60-$0.62 -$0.02-$0.62--5/15/2026Q1 2026-$0.77-$0.57+$0.20-$0.57--11/14/2025Q3 2025-$0.86-$0.65+$0.21-$0.65--8/14/2025Q2 2025-$0.55-$1.06 -$0.51-$1.06--5/15/2025Q1 2025-$0.61-$0.70 -$0.09-$0.70--3/18/2025Q4 2024-$0.50-$0.62 -$0.12-$0.62-- MiNK Therapeutics Earnings - Frequently Asked Questions When is MiNK Therapeutics' earnings date? MiNK Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 12th, 2026 based off last year's report dates. Learn more on INKT's earnings history. Did MiNK Therapeutics beat their earnings estimates last quarter? In the previous quarter, MiNK Therapeutics (NASDAQ:INKT) missed the analysts' consensus estimate of ($0.60) by $0.02 with a reported earnings per share (EPS) of ($0.62). Learn more on analysts' earnings estimate vs. INKT's actual earnings. How can I listen to MiNK Therapeutics' earnings conference call? The conference call for MiNK Therapeutics' latest earnings report can be listened to online. Listen to Conference Call How can I read MiNK Therapeutics' conference call transcript? The conference call transcript for MiNK Therapeutics' latest earnings report can be read online. Read Transcript How can I view MiNK Therapeutics' earnings report? MiNK Therapeutics' earnings report can be found in their filing with the SEC. View SEC filing How much profit does MiNK Therapeutics generate each year? MiNK Therapeutics (NASDAQ:INKT) has a recorded net income of -$12.49 million. INKT has generated -$2.40 earnings per share over the last four quarters. What is MiNK Therapeutics' EPS forecast for next year? MiNK Therapeutics' earnings are expected to grow from ($2.20) per share to ($2.19) per share in the next year. More Earnings Resources from MarketBeat Related Companies FTFT Earnings Date ALEC Earnings Date ADCT Earnings Date RNAC Earnings Date EVMN Earnings Date DTIL Earnings Date PEPG Earnings Date ELDN Earnings Date CGEN Earnings Date WHWK Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure WinnerThe Invisible AI Backbone: Corning's AI Fiber PlayWhy Tesla’s Upside Is About More Than a SpaceX MergerPalantir's Q3 Bar Is Higher Than It Looks: 3 Numbers to WatchAmkor's Mobile Business Is Slowing, But Its AI Ambitions Aren'tSherwin-Williams Remains Evergreen in a Frozen Housing MarketTaiwan Semiconductor Flexes Pricing Power on AI's Frontline Earnings data for NASDAQ:INKT is sourced from Fiscal.ai, with the most recent quarter reported on 8/13/2026. New results are added as companies report their earnings. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | Sponsored80 Days Until America's Rare Earth Supply Chain ShiftChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...Porter & Company | SponsoredNvidia's $550 Trillion ProblemDo not buy another AI stock until you've seen the arithmetic below. Nvidia is worth about $5.5 trillion. Al...Decentralized Masters | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredMissed this in 2024? Here’s your second chanceIn April 2024, gold had gone nowhere for 13 years - then it surged to a record high, more than doubling in val...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiNK Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MiNK Therapeutics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
